PipelineReview.com La Merie, S.L.
  PipelineReview » Store » Product Lines Cart Contents  |  Checkout  
Categories
Biotech & generics
Business & market
Cardiovascular & blood
Company Profiles
Dermatology
Diagnostics & biomarkers
Gastrointestinal
Genitourinary & gynecology
Healthcare
Infectious & toxicology
Medical device
Medical devices
Medical Equipment
Metabolism & endocrine
Neurology & psychiatry
Oncology
Ophthalmology & otorhino
Orthopedics & anesthesia
Pulmonary & respiratory
Research & Development
Rheumatoid & autoimmune
Target pipeline
Technologies
Periodicals
Publishers
Business Insights
Business Monitor International
Cambridge Healthtech Publishing
Datamonitor
Espicom
GBI Research
GlobalData
Jain PharmaBiotech
Kalorama Information
La Merie
Life Science Analytics
MarketsandMarkets
Scientia Veritas
Visiongain
Product Lines
Brief Report
Commercial & Pipeline Insight
Commercial & Pipeline Perspective
Commercial Insight
Competitor Analysis
Database
Drug Pipeline Report
Drug Profile
Emerging Company Profile
Financial Deals Industry Tracker
Full Report
Insight Pharma
PharmaVitae Profile
Pipeline Insight
Pipeline/Commercial Insight
Premium Company Profile
Stakeholder Insight
Stakeholder Opinions
Product Lines - Commercial & Pipeline Insight

Product Name:Release DatePrice
Pipeline and Commercial Insight: Schizophrenia - Second generation depots protect market valueOctober of 200811,971  EUR
[$15,200.00 USD]
Commercial and Pipeline Insight: HRT for Menopausal Symptoms – A new class restores an old marketApril of 200811,971  EUR
[$15,200.00 USD]
Commercial and Pipeline Insight: Opioids - Short acting and anti-abuse technologies set to fragment and grow the marketMarch of 200811,971  EUR
[$15,200.00 USD]
Commercial and Pipeline Insight: Fibromyalgia - Approvals legitimize condition and expose underserved patient populationFebruary of 200811,971  EUR
[$15,200.00 USD]
Commercial and Pipeline Insight: Vaccines for Adults and the Elderly - New blockbuster opportunities aheadFebruary of 200811,971  EUR
[$15,200.00 USD]
Commercial & Pipeline Insight: Hepatitis BOctober of 200711,971  EUR
[$15,200.00 USD]
Commercial & Pipeline Insight: Infertility - Optimizing a market bounded by social opinion and physician preferenceOctober of 200711,971  EUR
[$15,200.00 USD]
Commercial & Pipeline Insight: Hospital Antibacterials A market beyond MRSAAugust of 200711,971  EUR
[$15,200.00 USD]
Commercial & Pipeline Insight: Psoriasis - Anti-TNF's lead another indicationDecember of 200611,971  EUR
[$15,200.00 USD]
Commercial & Pipeline Insight: Inflammatory Bowel Disease - Competition Increases for the BiologicsNovember of 20068,978  EUR
[$11,400.00 USD]

Displaying 1 to 10 (of 10 products) Result Pages:  1 
Currencies
Shopping Cart more
0 items
Quick Find
Any wordAll words
Exact Phrase
Use keywords to find the product you are looking for.
Advanced Search
Bestsellers
01.Competitor Analysis: Erythropoietin (EPO)
02.Competitor Analysis: Anti-Obesity Biologics
03.Competitor Analysis: IGF-1R Antagonists
04.Competitor Analysis: Biogenerics & Therapeutic Proteins
05.Competitor Analysis: Coagulation Factors
Specials more

The Future of e-Clinical Trial Solutions - Market Forecasts to 2015, Competitive Benchmarking and Case Studies
2,757  EUR
[$3,500.00 USD]
2,343  EUR
[$2,975.00 USD]
Newest Product more
Prospects for Pharma Mergers, Acquisitions and Alliances 2010-2020
1,823  EUR
[£1,499.00 ]
La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L